 |
The Buyer’s Guide for Life Scientists |
|
| News and New Technologies in |
| Life Science |
|
|
| |
|
|
|
| Advertisement |
 |
 |
|
Freedom from consumables with BINDER CO2 incubators!
BINDER
When culturing cells, recurring costs for consumables and high risk of contamination go hand-in-hand. BINDER CO2 incubators with ANTI.PLENUM Design eliminate the costly ongoing replacement of HEPA filters, UV lights and H2O2; significantly reduce manual cleaning time, and maximize the time you can utilize your contamination-free CO2 incubator for cell culture.
BINDER CO2 incubators provide advantages not available in other brands:
- Eliminate the recurring costs of consumables for the unit’s lifetime.
- Built-in 180°C hot-air cycle sterilizes the interior without user intervention.
- Minimized growth surfaces exponentially reduce the risk of contamination.
Be convinced-- watch the videos. more »
|
 |
|
|
|
|
|
|
|
|
|
 |
 |
 |
|
|
|
 |
Supermini200 Benchtop WDXRF Spectrometer
Rigaku's Supermini200 WDXRF (wavelength dispersive x-ray fluorescence) spectrometer system combines WDXRF testing advantages in a smaller, economical design while reducing operational costs. This easy...
more » |
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
|
|
|
 |
Clinical Trials in CNS
London, United Kingdom
The SMi Group is proud to present their 11th annual Clinical Trials in CNS conference that will discuss the latest developments in preclinical discovery, clinical trial design, clinical trial management and the latest developments in neurodegenerative treatments. more » |
|
|
|
 |
Cell-Based Assays
Kensington, London
The conference will reflect the significant change driving current development in 3D cell culture, Ion Channels as drug targets, Primary Cell Assays and Stem Cells.. Cell-Based Assays is the place for senior scientists from assay development, pharmacology, screening and related fields to meet and ...
more » |
|
|
|
 |
Point of Care Diagnostics
London, United Kingdom
With point of care constantly at the forefront of the biotechnology and healthcare markets, the need for up to date information on both the emerging technologies, and the market opportunities is paramount. Challenges still remain about the logistics of companion diagnostics, the legitimacy of ...
more » |
|
|
|
|
|
|
| |
|
|
|
|